Integrated Filing — IndAS



General information about company

Scrip Code 544339
NSE Symbol LAXMIDENTL
MSEI Symbol NOTLISTED
ISIN INE0WO601020
Name of company Laxmi Dental Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 03-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Integrated Dental Products
Start date and time of board meeting 03-11-2026   16:00:00
End date and time of board meeting 03-11-2026   17:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 26-03-2026
Indicate Company website link for updated RPT policy of the Company https://laxmidentallimited.com/public/investors/policies/new/Related%20Party%20Transaction%20Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
It is not applicable for the Quarter ended September 30, 2026.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 5,818.70 11,338.70
Other income 149.60 320.90
Total income 5,968.30 11,659.60
2 Expenses
(a) Cost of materials consumed 1,351.00 2,889.60
(b) Purchases of stock-in-trade 77.50 221.10
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 195.20 (75.40)
(d) Employee benefit expense 2,338.10 4,534.10
(e) Finance costs 30.30 55.80
(f) Depreciation, depletion and amortisation expense 393.50 719.90
(f) Other Expenses
1 Other expenses 982.80 2,009.10
Total other expenses 982.80 2,009.10
Total expenses 5,368.40 10,354.20
3 Total profit before exceptional items and tax 599.90 1,305.40
4 Exceptional items 0.00 0.00
5 Total profit before tax 599.90 1,305.40
6 Tax expense
7 Current tax 68.90 276.60
8 Deferred tax 118.40 87.60
9 Total tax expenses 187.30 364.20
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 412.60 941.20
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 54.80 143.30
16 Total profit (loss) for period 467.40 1,084.50
17 Other comprehensive income net of taxes 2.20 4.40
18 Total Comprehensive Income for the period 469.60 1,088.90
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,100.60 1,100.60
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.85 1.97
Diluted earnings (loss) per share from continuing operations 0.85 1.97
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.85 1.97
Diluted earnings (loss) per share from continuing and discontinued operations 0.85 1.97
24 Debt equity ratio 0 0
25 Debt service coverage ratio 11.500 11.0900
26 Interest service coverage ratio 33.7900 37.300
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to the Unaudited Standalone Financial Results: 1. The unaudited standalone financial results of the Company for the quarter and half year ended 30 September 2026 have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and are in compliance with the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The aforesaid results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 03 November 2026. The Statutory Auditors of the Company have carried out a limited review of the above results and have expressed an unmodified opinion. 2. As permitted by paragraph 4 of Indian Accounting Standard (Ind AS) 108 Operating Segments, notified under Section 133 of the Companies Act, 2013, read together with the relevant rules issued thereunder, if a single financial report contains both consolidated financial statements and the separate financial statements of the parent, segment information needs to be presented only on the basis of the consolidated financial statements. Thus, disclosure required by Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on segment-wise revenue, results and capital employed is given in consolidated financial results. 3. Effective 21 November 2025, the Government of India consolidated 29 existing labour regulations into four Labour Codes, namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes have resulted in material increase in provision for gratuity expenses on account of recognition of past service costs. Based on the requirements of New Labour Codes and relevant Accounting Standard, the Company had assessed and accounted the estimated incremental impact of INR 51.56 million as an Exceptional Item in the standalone audited statement of financial results for the year ended 31 March 2026. The Company continues to monitor developments pertaining to the Labour Codes and will evaluate any further impact on the measurement of liabilities relating to employee benefits. 4. The Company had raised funds through an Initial Public Offer (IPO), the objects of which were set out in the Prospectus dated 16 January 2025 filed with the Stock Exchanges, the Registrar of Companies and the Securities and Exchange Board of India. The shareholders of the Company, by way of a special resolution passed at the 22nd Annual General Meeting held on 25 September 2026, approved the variation in the objects of the IPO and the extension of the timeline for utilisation of the IPO proceeds, pursuant to the provisions of Sections 13(8) and 27 of the Companies Act, 2013 and other applicable provisions. Accordingly, the unutilised IPO proceeds earmarked towards Funding of capital expenditure requirements for purchase of new machinery for our Company and Investments in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery have been reallocated towards the newly added objects, to be utilised over Financial Years 2026-27 and 2027-28. The utilisation of the proceeds of initial public offer (IPO) as on 30 September 2026 is summarised as below: UTILISATION OF IPO PROCEEDS AS ON 30 SEPTEMBER 2026 (INR in millions) =========================================================================== Objects of the issue (as Revised Unutilised as per offer objects (post Utilised up to on Sr. No. Particulars document) variation) 30-Sep-2026 30-Sep-2026 ----------------------------------------------------------------------------------------------------------------------------------------------------- 1. Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our company 229.84 229.84 229.84 - 2. Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings 46.00 46.00 46.00 - 3. Funding of capital expenditure requirements for purchase of new machinery for our Company 435.07 177.81 177.81 - 4. Investments in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery 250.04 26.27 26.27 - 5. General Corporate purposes 320.75 320.75 320.75 - Total (1 to 5) 1,281.70 800.67 800.67 - Newly added objects 6. Acquisition of land and construction of building and infrastructure for manufacturing plant for dental laboratory and dental aligner facility - 268.96 - 268.96 7. Purchase of movable assets including machinery, computer and computer equipment, furniture and fixtures and office equipment for the existing and/or newly constructed facility - 212.07 13.43 198.64 Total (6 to 7) - 481.03 13.43 467.60 Total utilisation of funds 1,281.70 1,281.70 814.10 467.60 =========================================================================== Out of the net proceeds which were unutilised as at 30 September 2026, INR 467.60 million are temporarily invested in fixed deposits with banks. 5. During the year ended 31 March 2026, the Board of Directors, at its meeting held on 26 March 2026, approved the Scheme of Merger of Bizdent Devices Private Limited, a wholly owned subsidiary, with the Company, Laxmi Dental Limited. The Scheme is currently pending approval of the Regional Director. Pending receipt of the requisite statutory and regulatory approvals, no effect of the proposed merger has been given in these standalone financial results. 6. The standalone financial results of the Company are available on the Company's website (www.laxmidentallimited.com) and stock exchanges websites, BSE (www.bseindia.com) and NSE (www.nseindia.com), where the shares of the Company are listed.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,599.80
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 287.10
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 6,851.50
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 1,243.20
Total of other non-current financial assets 1,243.20
Total non-current financial assets 8,094.70
Deferred tax assets (net) 520.50
Other non-current assets
1 Right-of-use assets 1,132.70
2 Income tax assets (net) 281.30
3 Other non-current assets 0.00
Total of other non-current assets 1,414.00
Total non-current assets 14,916.10
2 Current assets
Inventories 2,498.20
Current financial asset
Current investments 715.80
Trade receivables, current 2,955.00
Cash and cash equivalents 136.70
Bank balance other than cash and cash equivalents 78.00
Loans, current 133.10
Other current financial assets
Total of other current financial assets 6,339.80
Total current financial assets 10,358.40
Current tax assets (net) 0.00
Other current assets
1 Other current assets 1,990.10
Total of other current assets 1,990.10
Total current assets 14,846.70
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 29,762.80
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,100.60
Other equity 24,780.30
Total equity attributable to owners of parent 25,880.90
Non controlling interest
Total equity 25,880.90
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 887.50
2 Other financial liabilities 61.90
Total of other non-current financial liabilities 949.40
Total non-current financial liabilities 949.40
Provisions, non-current 239.90
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 0.00
Total of other non-current liabilities 0.00
Total non-current liabilities 1,189.30
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 267.70
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 538.70
Total Trade payable 806.40
Other current financial liabilities
1 Lease liabilities 305.10
2 Other financial liabilities 935.60
Total of other current financial liabilities 1,240.70
Total current financial liabilities 2,047.10
Other current liabilities 442.20
1 Other current liabilities 442.20
Total of other current liabilities 442.20
Provisions, current 203.30
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 2,692.60
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 3,881.90
Total equity and liabilites 29,762.80
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit liabilities/assets 2.90 5.80
Total Amount of items that will not be reclassified to profit and loss 2.90 5.80
2 Income tax relating to items that will not be reclassified to profit or loss 0.70 1.40
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 2.20 4.40



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,305.40
Adjustments for reconcile profit (loss)
Adjustments for finance costs 55.80
Adjustments for decrease (increase) in inventories (429.40)
Adjustments for decrease (increase) in trade receivables, current 90.30
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (498.70)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (417.10)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (5.60)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (560.10)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 719.90
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 25.10
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 204.30
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 4.80
Adjustments for dividend income 0.00
Adjustments for interest income 147.60
Adjustments for share-based payments 50.40
Adjustments for fair value losses (gains) (23.80)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 143.30
Total adjustments for reconcile profit (loss) (788.40)
Net cash flows from (used in) operations 517.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 293.50
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 223.50
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 312.10
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,112.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 5.30
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 25.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 140.70
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 405.70
Net cash flows from (used in) investing activities (283.80)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 1.40
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 136.10
Dividends paid 0.00
Interest paid 55.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (190.50)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (250.80)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (250.80)
Cash and cash equivalents cash flow statement at beginning of period 387.50
Cash and cash equivalents cash flow statement at end of period 136.70





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 16-01-2025
Amount Raised 69,805.80
Report filed for Quarter ended 30-09-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA LIMITED
Is there a Deviation / Variation in use of funds raised Yes
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders Yes
If Yes, Date of shareholder Approval 25-09-2026
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company NA 2,298.40 2,298.40 2,298.40 0.00
2 Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. NA 460.00 460.00 460.00 0.00
3 Funding the capital expenditure requirements for purchase of new machinery for our Company. Yes 4,350.70 1,778.10 1,778.10 2,572.60 Object no 3 and 4 reallocated to Object no 6 and 7
4 Investment in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery. Yes 2,500.40 262.70 262.70 2,237.70 Object no 3 and 4 reallocated to Object no 6 and 7
5 General corporate purposes. NA 3,207.50 3,207.50 3,207.50 0.00
6 Acquisition of Land and Construction of Building and infrastructure for manufacturing plant of dental laboratory and dental aligner facility Yes 0.00 2,689.60 0.00 2,689.60 Object no 3 and 4 reallocated to Object no 6 and 7
7 Purchase of movable assets including machinery, computer and computer equipment, furniture & fixtures, office equipment for the existing and/or newly constructed facility Yes 0.00 2,120.70 134.30 2,120.70 Object no 3 and 4 reallocated to Object no 6 and 7


Signatory Details

Name of signatory Sameer Kamlesh Merchant
Designation of person CEO
Place MUMBAI
Date 03-11-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Laxmi Dental Limited Mr. Rajesh Khakhar Whole time Director & Chairman Remuneration 172.80 Approved 48.00 8.00 8.00
2 Laxmi Dental Limited Mr. Sameer Merchant CEO and Managing Director Remuneration 172.80 Approved 48.00 8.00 8.00
3 Laxmi Dental Limited Mr. Dharmesh Dattani Chief Finance Officer Remuneration 102.00 Approved 33.00 5.50 5.50
4 Laxmi Dental Limited Mr. Rajesh Dalal Independent Director Remuneration 15.00 Approved 7.50 0.00 3.40
5 Laxmi Dental Limited Mrs. Anjana Grewal Independent Director Remuneration 15.00 Approved 7.50 0.00 3.40
6 Laxmi Dental Limited Mr. Devesh Chawla Independent Director Remuneration 7.50 Approved 3.80 0.00 1.70
7 Laxmi Dental Limited Mr. Anil Arora Independent Director Remuneration 7.50 Approved 3.80 0.00 1.70
8 Laxmi Dental Limited Mr. Parth Khakhar Relative of directors And KMP Remuneration 93.60 Approved 49.80 7.80 8.80
9 Laxmi Dental Limited Mr. Manan Khakhar Relative of directors And KMP Remuneration 48.00 Approved 27.00 4.00 5.00
10 Laxmi Dental Limited Mrs. Bhavi Merchant Relative of directors And KMP Remuneration 48.00 Approved 12.00 2.00 2.00
11 Laxmi Dental Limited Mr. Shubh Sanjay Khakhar Relative of directors And KMP Remuneration 30.00 Approved 15.00 2.50 2.50
12 Laxmi Dental Limited Mrs. Jigna R Khakhar Relative of directors And KMP Remuneration 24.00 Approved 12.00 2.00 2.00
13 Laxmi Dental Limited Mr. Hasmukh Khakhar Relative of directors And KMP Remuneration 18.00 Approved 9.00 1.50 1.50
14 Laxmi Dental Limited Ms. Siddhi Khakhar Relative of directors And KMP Remuneration 30.00 Approved 17.30 2.50 3.30
15 Laxmi Dental Limited Mr. Rajesh Khakhar Whole time Director & Chairman Any other transaction Rent Paid 7.80 Approved 3.80 0.00 0.00
16 Laxmi Dental Limited Mr. Rajesh Khakhar Whole time Director & Chairman Any other transaction Security Deposit 3.60 Approved 0.00 3.60 3.60
17 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Purchase of goods or services 243.30 Approved 16.40 0.00 0.00
18 Laxmi Dental Limited Bizdent Devices Private Limited Subsidiary Purchase of goods or services 0.00 NA 9.90 1.10 2.80
19 Laxmi Dental Limited IDBG AI Dent Global Private Limited Jointly controlled Entity Purchase of goods or services 200.00 Approved 7.50 0.00 0.00
20 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Purchase of goods or services 0.00 NA 0.00 0.80 0.00
21 Laxmi Dental Limited Rich Smile Design LLP Subsidiary Purchase of goods or services 15.10 Approved 0.00 9.70 0.00
22 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Sale of goods or services 2,730.70 Approved 1,471.90 49.70 (88.40)
23 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Sale of goods or services 96.40 Approved 17.80 5.60 1.70
24 Laxmi Dental Limited Bizdent Devices Private Limited Wholly owned Subsidiary Sale of goods or services 0.00 NA 226.30 36.00 51.80
25 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Sale of goods or services 76.20 Approved 65.00 1.10 25.60
26 Laxmi Dental Limited IDBG AI Dent Global Private Limited Jointly controlled Entity Sale of goods or services 200.00 Approved 21.80 0.00 23.00
27 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Interest received 21.00 Approved 5.90 0.00 0.00
28 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Any other transaction Rent Received 6.10 Approved 3.00 0.00 0.00
29 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Any other transaction Security Deposit 2.90 Approved 0.00 2.90 2.90
30 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Any other transaction Share of Profit/(Loss) in LLP 1,103.00 Approved 143.30 1,291.30 1,442.60
31 Laxmi Dental Limited IDBG AI Dent Global Private Limited Jointly controlled Entity Any other transaction Share of Profit/(Loss) in LLP (81.70) Approved (13.70) 0.00 0.00
32 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Loan 50.00 Approved 25.00 100.00 125.00 Loan 10.500 5 years from the date of disbursment Unsecured For Principal Business Activities Textual Information(1)
33 Laxmi Dental Limited Bizdent Devices Private Limited Wholly owned Subsidiary Any other transaction ESOP Reimburstment 0.00 NA 53.80 79.00 25.20
34 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Investment 0.00 NA 0.00 1,505.20 1,505.20
35 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Investment 0.00 NA 0.00 700.00 700.00
36 Laxmi Dental Limited Bizdent Devices Private Limited Wholly owned Subsidiary Investment 0.00 NA 0.00 4,442.50 4,442.50
37 Laxmi Dental Limited Rich Smile Design LLP Subsidiary Investment 0.00 NA 0.00 0.70 0.70
38 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Investment 0.00 NA 0.00 3.00 3.00
39 Laxmi Dental Limited IDBG AI Dent Global Private limited Jointly controlled Entity Investment 0.00 NA 0.00 200.10 200.10
40 Signature Smiles Dental Clinic Private Limited Bizdent Devices Private Limited Sister Concern Purchase of goods or services 500.00 Approved 4.30 0.90 1.40
41 Signature Smiles Dental Clinic Private Limited Bhavi Merchant Relative of directors And KMP Remuneration 500.00 Approved 8.00 2.00 0.00
42 Bizdent Devices Private Limited Bhavi Merchant Relative of directors And KMP Remuneration 500.00 Approved 5.50 0.00 2.50
43 Bizdent Devices Private Limited Sameer Merchant Director Remuneration 500.00 Approved 18.00 3.00 3.00
44 Bizdent Devices Private Limited Rajesh Khakhar Director Remuneration 500.00 Approved 18.00 3.00 3.00
45 Bizdent Devices Private Limited Dharmesh Dattani Relative of directors And KMP Remuneration 500.00 Approved 18.00 3.00 3.00
46 Bizdent Devices Private Limited IDBG AI Dent Global Private Limited Joint Venture of Holding Company Purchase of goods or services 500.00 Approved 50.10 0.00 (6.50)
47 Bizdent Devices Private Limited ECGPlus Technologies Private Limited Associate of Holding Company Purchase of goods or services 500.00 Approved 10.00 0.00 0.00
48 Laxmi Dental Lab USA INC Kunal Merchant Relative of directors And KMP Remuneration 0.00 NA 64.40 5.00 5.30
49 Laxmi Dental Lab USA INC Rupal Bhimjiyani Relative of directors And KMP Remuneration 0.00 NA 25.60 1.90 2.10
50 Laxmi Dental Lab USA INC Sonal Desai Relative of directors And KMP Remuneration 0.00 NA 13.90 0.00 1.10
51 Laxmi Dental Lab USA INC Amrish Desai Relative of directors And KMP Remuneration 0.00 NA 62.40 4.90 5.10
52 Laxmi Dental Lab USA INC Parag Bhimjiyani Relative of directors And KMP Remuneration 0.00 NA 50.20 3.90 4.10
Total value of transaction during the reporting period 2,699.80



Text Block

Textual Information(1) Loan Given